PROFUSA, INC. Proceeds from Short-term Debt
PROFUSA, INC. (PFSA) had Proceeds from Short-term Debt of $1.30 million as of 2021-05-25, per its S-1/A filed 2026-05-01.
Financial Statements › Cash Flow › Financing Activities
us-gaap:ProceedsFromShortTermDebt · last filed 2026-05-01
- 2021-05-25: Proceeds from Short-term Debt $1.30M.
| Period end | Proceeds from Short-term Debt |
|---|---|
| 2021-05-25 | $1.30M S-1/A · filed 2026-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |